Labiotech.eu

News and Trends 7 Nov 2015

What Happened this Week? BIO-Europe 2015, mRNA deal, Cellectis CAR-T

Monday: The French Scientist Who Also ‘Discovered’ CRISPR is Finally Recognized with a Prize too Tuesday: €100 Million Investment Round Prepares CureVac For Vaccine Expansion Wednesday: €1.37Bn Deal for Sanofi with Germany’s Fastest Growing mRNA Cancer Biotech Thursday: Damn, that was BIO-Europe 2015 in Munich! Friday: Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on […]

November 7, 2015 - 1 minutemin - By Philip Hemme

News and Trends 6 Nov 2015

Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?

About 30%. That’s how Cellectis‘ NASDAQ stock price has jumped between the 4th and the 5th of November. But why? Basically, because of the first human success of their allogeneic CAR-T therapy! The Great Ormond Street Hospital (UK) treated a young patient with refractory relapsed Acute Lymphoblastic Leukemia (ALL) with Cellectis’ allogeneic UCART19 product candidate in June. To […]

November 6, 2015 - 2 minutesmins - By Jerome Topsent

News and Trends 6 Nov 2015

The Danish ‘Algae Cathedral’ is Manufacturing Proteins that Make Flamingos Pink

A project at the Symbiosis Center Denmark has found a way to use Algae brewing bio-reactors to produce proteins for use in the Biotech industry. One such protein is the hotly sought after in biomedical research is Astaxanthin, also known for making Flamingo birds pink. The Center brings together many biotech businesses, which recycle each […]

November 6, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 6 Nov 2015

Biotech of the Week: Synpromics, the Scottish company enabling precise Gene Expression

This week we leave the wonderful weather of Mallorca and head North, through France, England and across Hadrian’s Wall where we land in the capital city of Scotland, Edinburgh. This city is famous for many things, being one of the most haunted cities in the world to being built on an extinct volcano however, it […]

November 6, 2015 - 2 minutesmins - By Dani Bancroft

materials for life cardiff bath cambridge

News and Trends 5 Nov 2015

Living Buildings ‘Self-Heal’ in the UK with Calcium Carbonate Secreting Bacteria

Using Biotech to make living, self-sustaining buildings is a new level of innovation which could revolutionize construction engineering. The ‘Materials For Life‘ Project in Wales (UK) is literally producing stones which self-repair and resist erosion! The University of Cardiff (Wales) leads a team with the University of Bath (SW England) and the University of Cambridge […]

November 5, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 5 Nov 2015

German Bioinformatics Start-Up wants to Change Studies of GMO Crops

High-Tech Grüenderfonds (HTGF) has invested in a spin-off from the Max Planck Institute for Developmental Biology and University of Tübingen. Computomics’ has a pioneering agricultural project involving next generation sequencing (NGS) of GMO crops. Computomics is the biotech which has caught HTGF’s interest. Based in Tübingen (Germany), this bio-informatics start-up tackle genomic analysis of agricultural […]

November 5, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 5 Nov 2015

Damn, that was BIO-Europe 2015 in Munich!

We are now back in Berlin after three (intense) days at BIO-Europe 2015 in Munich. It was definitely a great fair. We covered the event with articles and videos to give you a live insight, (almost) as if you were there. Everything is below 😉 Day 1 : EU’s biggest Biotech Fair, BIO-Europe 2015, […]

November 5, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 4 Nov 2015

€1.37Bn Deal for Sanofi with Germany’s Fastest Growing mRNA Cancer Biotech

Sanofi is now the latest Biotech lining up to partner with BioNTech from Mainz (Germany), for license of their mRNA Immuno-oncology platform in a€1.37Bn long-term development deal. Novel mRNA targets in Immuno-onology is a top-shelf cancer R&D area, with Germany’s CureVac also attracting another €100M yesterday for their mRNA platform (which targets lung and prostate […]

November 4, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 4 Nov 2015

Last exclusive interview from #BIO-Europe 2015: Andre Hoekema, SVP Corporate Development of Galapagos

And here is the fourth interview I did at BIO-Europe 2015. This time, I am with Andre Hoekema, top-executive from the belgian Biotech success-story, Galapagos. We recently covered extensively the 400-employee company based north of Bruxelles. It made the biggest IPO ever by a EU Biotech on the NASDAQ, raising 270 million euros. It also recently had […]

November 4, 2015 - 1 minutemin - By Philip Hemme

News and Trends 4 Nov 2015

Transformational deals that shaped the Biotech industry in 2015 #BIO-Europe 2015

The Biotech industry relies a lot on partnering and deals. And 2015 has already been an active year. This was the theme of the second keynote conference from BIO-Europe 2015. It gathered four high-level speakers: The roundtable started with a summary of each companies’ activity in deals. Everyone has been busy, but Celgene seemed to […]

November 4, 2015 - 3 minutesmins - By Philip Hemme

peter Llewellyn Davies medigene interview

News and Trends 3 Nov 2015

Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech

This is the third interview we publish from BIO (yes, we are working hard). It comes after the interview of Simon Moroney, CEO of MorphoSys and Jane Dancer, CBO of F-star. Medigene is another big/famous Biotech company of Munich, Germany. It was founded over 20 years ago and is now specialised in cell-based therapies. It counts […]

November 3, 2015 - 1 minutemin - By Philip Hemme

News and Trends 3 Nov 2015

€100 Million Investment Round Prepares CureVac For Vaccine Expansion

“The RNA People” at CureVac in Tübingen (Germany) have a new €100M investment into their RNA platform, which has prophylactic purposes for common viruses, pipeline candidates for prostate cancer, lung cancer and research into vaccines for HIV, Tuborculosis and Rabies. Indeed, the financial success surrounding their mRNA work has been startlingly impressive, with the EU […]

November 3, 2015 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

What Happened this Week? BIO-Europe 2015, mRNA deal, Cellectis CAR-T

Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?

The Danish ‘Algae Cathedral’ is Manufacturing Proteins that Make Flamingos Pink

Biotech of the Week: Synpromics, the Scottish company enabling precise Gene Expression

Living Buildings ‘Self-Heal’ in the UK with Calcium Carbonate Secreting Bacteria

German Bioinformatics Start-Up wants to Change Studies of GMO Crops

Damn, that was BIO-Europe 2015 in Munich!

€1.37Bn Deal for Sanofi with Germany’s Fastest Growing mRNA Cancer Biotech

Last exclusive interview from #BIO-Europe 2015: Andre Hoekema, SVP Corporate Development of Galapagos

Transformational deals that shaped the Biotech industry in 2015 #BIO-Europe 2015

Exclusive from BIO-Europe 2015: Interview of Peter Llewellyn-Davies, CFO at Medigene, Munich-based Immunotherapy Biotech

€100 Million Investment Round Prepares CureVac For Vaccine Expansion

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!